ID: ALA5269035

Max Phase: Preclinical

Molecular Formula: C33H46N6O11

Molecular Weight: 702.76

Associated Items:

Representations

Canonical SMILES:  Cc1cn([C@H]2C[C@H](n3cc(CNC(=O)CCCC(=O)O[C@@H]4O[C@@H]5O[C@@]6(C)CC[C@H]7[C@H](C)CC[C@@H]([C@H]4C)[C@@]57OO6)nn3)[C@@H](CO)O2)c(=O)[nH]c1=O

Standard InChI:  InChI=1S/C33H46N6O11/c1-17-8-9-22-19(3)29(47-30-33(22)21(17)10-11-32(4,48-30)49-50-33)46-27(42)7-5-6-25(41)34-13-20-15-39(37-36-20)23-12-26(45-24(23)16-40)38-14-18(2)28(43)35-31(38)44/h14-15,17,19,21-24,26,29-30,40H,5-13,16H2,1-4H3,(H,34,41)(H,35,43,44)/t17-,19-,21+,22+,23+,24-,26-,29-,30-,32-,33-/m1/s1

Standard InChI Key:  PBXFJCHJMYUCGA-IACHSUTPSA-N

Associated Targets(Human)

KB 17409 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 702.76Molecular Weight (Monoisotopic): 702.3225AlogP: 1.50#Rotatable Bonds: 10
Polar Surface Area: 207.35Molecular Species: NEUTRALHBA: 15HBD: 3
#RO5 Violations: 2HBA (Lipinski): 17HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.96CX Basic pKa: 0.03CX LogP: 2.22CX LogD: 2.22
Aromatic Rings: 2Heavy Atoms: 50QED Weighted: 0.24Np Likeness Score: 1.30

References

1. Gao F, Sun Z, Kong F, Xiao J..  (2020)  Artemisinin-derived hybrids and their anticancer activity.,  188  [PMID:31945642] [10.1016/j.ejmech.2020.112044]

Source